Major Companies to Ramp Up Vaccine Adjuvant Production in 2021
According to Visiongain analysis, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global vaccine adjuvants market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the vaccine adjuvants market. For instance, in May 2020; GlaxoSmithKline announced that it will expand production of vaccine adjuvants to 1 billion doses in 2021. Additionally, the company announced that the vaccine adjuvants would be supplied to partner’s of COVID-19 vaccine candidates. These factors are projected to boost vaccine adjuvants market growth over the forecast period from 2021 to 2031.
Rising Demand from Emerging Economies to Offer Lucrative Revenue Generation Avenues
For the companies operating in the global vaccine adjuvants market, there is an immense opportunity from emerging economies across the globe. In the emerging economies, vaccine manufacturers and respective governments are investing in enhancing production capacity, which is anticipated to reduce the amount of protein required per dose over the forecast period. In addition to the demand arising from the ageing population and rising birth rates, the economic growth across the emerging markets is another major factor that is driving demand for the vaccine adjuvants.
Discover how to stay ahead
Our 310+ page report provides 450+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Vaccine Adjuvants Market. See how to exploit the opportunities.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, SWOT Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and sub-markets
Type
• Pathogen
• Adjuvant Emulsion
• Particulate
• Combination
• Others
Route of Administration
• Intramuscular
• Subcutaneous
• Intradermal
• Others
Disease Type
• Infectious Diseases
• Cancer
• Others
End-User
• Pediatric
• Adults
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 14 leading national markets:
By Region
• North America
– U.S.
– Canada
• Europe
– Germany
– France
– UK
– Italy
– Spain
– Rest of Europe
• Asia Pacific
– China
– Japan
– India
– Rest of Asia Pacific
• Latin America
– Brazil
– Mexico
– Rest of Latin America
• Middle East & Africa
– GCC
– South Africa
– Rest of Middle East & Africa
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for Vaccine Adjuvants Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Vaccine Adjuvants Market report helps you
In summary, our 310+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Vaccine Adjuvants Market, with forecasts for Type, Route of Administration, Disease Type, and End-User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 14 key national markets– See forecasts for the Vaccine Adjuvants market in North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, GCC, and South Africa among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 13 of the major companies involved in the Vaccine Adjuvants Market. Some of the company’s profiled in this report GSK, CSL, Agenus, Adjuvance, Novavax, SPI Pharma, Invivogen, Avanti Polar Lipids, Seppic, Croda, MVP Laboratories, OZ Biosciences, and Dynavax.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our new report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Vaccine Adjuvants Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Vaccine Adjuvants Market Report 2021-2031: Forecasts by Type (Pathogen, Adjuvant Emulsion, Particulate, Combination, Others), by Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), by Disease Type (Infectious Diseases, Cancer, Others), by End-user (Pediatric, Adults, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Vaccine Adjuvants Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Vaccine Adjuvants Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 COVID-19 Impact: Recovery Scenarios
1.6.2 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Growing Investments in Vaccine Development
3.1.2 Rising R&D Activities in Vaccine Development
3.1.3 Growing Government Focus on Immunization Programs
3.2 Restraints
3.2.1 Cost of Vaccine Production is a Major Concern
3.2.2 Longer Timelines Required for Vaccine Production
3.3 Opportunities
3.3.1 Use of Adjuvants to Extend Implications
3.3.2 Rising Demand from Emerging Economies
3.4 Trends
3.4.1 Regulatory Issues in Introduction of New Adjuvants
3.4.2 Government Contracts & Grants
3.5 SWOT Analysis
3.5.1 Strengths
3.5.1.1 Ageing Population
3.5.1.2 Prevention is Better Than Cure
3.5.1.3 Demand from Emerging Market Continue
3.5.1.4 Promising R&D Pipeline
3.5.1.5 Increasing Awareness
3.5.2 Weaknesses
3.5.2.1 High Manufacturing Costs
3.5.2.2 Time Constraints
3.5.2.3 Barriers to Market Entry
3.5.3 Opportunities
3.5.3.1 Constant Improvements in Vaccine Technology
3.5.3.2 Shifting Focus on Adults Vaccines
3.5.4 Threats
3.5.4.1 Oligarchic Presence of Pharmaceutical Giants
3.5.4.2 Productivity Gaps
3.6 Industry analysis – PEST Analysis
3.6.1 Political
3.6.1.1 Governments Play Crucial Roles in Vaccination
3.6.2 Economical
3.6.2.1 High Cost of Production
3.6.2.2 Soaring Vaccine Demands from Emerging Economies
3.6.3 Social
3.6.3.1 Maintaining a Healthy Workforce
3.6.3.2 Public Hesitation: Fear of Unwanted Side Effects
3.6.4 Technological
3.6.4.1 Evolution of Vaccine Technology Pave the Way for Prophylactics and Therapeutics
4 Vaccine Adjuvants Market by Type
4.1 Pathogen Segment Market Forecast, 2021-2031
4.1.1 Recovery Scenarios (V, U, W, L)
4.2 Adjuvant Emulsion Segment Market Forecast, 2021-2031
4.2.1 Adjuvant Emulsion to Witness the Highest Growth Rate During the Forecast Period
4.2.2 Recovery Scenarios (V, U, W, L)
4.3 Particulate Segment Market Forecast, 2021-2031
4.3.1 Particulate Sub-Segment Accounts for Majority of the Market Share
4.3.2 Recovery Scenarios (V, U, W, L)
4.4 Combination Segment Market Forecast, 2021-2031
4.4.1 Recovery Scenarios (V, U, W, L)
4.5 Others Segment Market Forecast, 2021-2031
4.5.1 Recovery Scenarios (V, U, W, L)
5 Vaccine Adjuvants Market by Route of Administration
5.1 Intramuscular Segment Market Forecast, 2021-2031
5.1.1 Intramuscular Sub-Segment Accounts for Majority of the Market Share
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Subcutaneous Segment Market Forecast, 2021-2031
5.2.1 Recovery Scenarios (V, U, W, L)
5.3 Intradermal Segment Market Forecast, 2021-2031
5.3.1 Intradermal Sub-Segment to Witness the Highest Growth Rate from 2021 to 2031
5.3.2 Recovery Scenarios (V, U, W, L)
5.4 Others Segment Market Forecast, 2021-2031
5.4.1 Recovery Scenarios (V, U, W, L)
6 Vaccine Adjuvants Market by Disease Type
6.1 Infectious Diseases Segment Market Forecast, 2021-2031
6.1.1 Infectious Diseases Sub-Segment Account for the Largest Market Share
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Cancer Segment Market Forecast, 2021-2031
6.2.1 Cancer Sub-Segment to Witness the Highest Growth Rate from 2021 to 2031
6.2.2 Recovery Scenarios (V, U, W, L)
6.3 Others Segment Market Forecast, 2021-2031
6.3.1 Recovery Scenarios (V, U, W, L)
7 Vaccine Adjuvants Market by End-User
7.1 Pediatric Segment Market Forecast, 2021-2031
7.1.1 Pediatric Sub-Segment Accounts for the Largest Market Share
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 Adults Segment Market Forecast, 2021-2031
7.2.1 Recovery Scenarios (V, U, W, L)
7.3 Others Segment Market Forecast, 2021-2031
7.3.1 Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Vaccine Adjuvants Market Forecasts 2021-2031
8.1 Global Vaccine Adjuvants Market by Region Forecast 2021-2031
8.2 Recovery Scenarios (V, U, W, L)
9 North America Vaccine Adjuvants Market, 2021-2031
9.1 North America Vaccine Adjuvants Market by Country Forecast 2021-2031
9.2 North America Vaccine Adjuvants Market Forecast by Type
9.3 North America Vaccine Adjuvants Market Forecast by Route of Administration
9.4 North America Vaccine Adjuvants Market Forecast by Disease Type
9.5 North America Vaccine Adjuvants Market Forecast by End-User
9.6 U.S. Vaccine Adjuvants Market Forecast, 2021-2031
9.6.1 U.S. is the Largest Vaccine Market Globally
9.6.2 Recovery Scenarios (V, U, W, L): U.S. Vaccine Adjuvants Market Forecast, 2021-2031
9.7 Canada Vaccine Adjuvants Market Forecast, 2021-2031
9.7.1 Recovery Scenarios (V, U, W, L): Canada Vaccine Adjuvants Market Forecast, 2021-2031
10 Europe Vaccine Adjuvants Market, 2021-2031
10.1 Europe Vaccine Adjuvants Market by Country Forecast 2021-2031
10.2 Europe Vaccine Adjuvants Market Forecast by Type
10.3 Europe Vaccine Adjuvants Market Forecast by Route of Administration
10.4 Europe Vaccine Adjuvants Market Forecast by Disease Type
10.5 Europe Vaccine Adjuvants Market Forecast by End-User
10.6 Germany Vaccine Adjuvants Market Forecast, 2021-2031
10.6.1 Germany Accounts for Majority of European Vaccine Adjuvants Market
10.6.2 Economic Downturn and Ripple Effect
10.6.3 Recovery Scenarios (V, U, W, L): Germany Vaccine Adjuvants Market Forecast, 2021-2031
10.7 UK Vaccine Adjuvants Market Forecast, 2021-2031
10.7.1 UK is the Second Largest Market in European Region
10.7.2 Recovery Scenarios (V, U, W, L): UK Vaccine Adjuvants Market Forecast, 2021-2031
10.8 France Vaccine Adjuvants Market Forecast, 2021-2031
10.8.1 France is the Third Largest Vaccine Adjuvants Market in Europe
10.8.2 French Healthcare System to Fuel Further Growth
10.8.3 Recovery Scenarios (V, U, W, L): France Vaccine Adjuvants Market Forecast, 2021-2031
10.9 Italy Vaccine Adjuvants Market Forecast, 2021-2031
10.9.1 Elderly Population to Fuel Italian Vaccine Adjuvants Market Growth
10.9.2 Recovery Scenarios (V, U, W, L): Italy Vaccine Adjuvants Market Forecast, 2021-2031
10.10 Spain Vaccine Adjuvants Market Forecast, 2021-2031
10.10.1 Ageing Population to Boost Spanish Vaccine Adjuvants Market Growth
10.10.2 Economic Challenges to Challenges Spanish Vaccine Adjuvants Market Growth
10.10.3 Recovery Scenarios (V, U, W, L): Spain Vaccine Adjuvants Market Forecast, 2021-2031
10.11 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031
10.11.1 Recovery Scenarios (V, U, W, L): Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031
11 Asia Pacific Vaccine Adjuvants Market, 2021-2031
11.1 Asia Pacific Vaccine Adjuvants Market by Country Forecast 2021-2031
11.2 Asia Pacific Vaccine Adjuvants Market Forecast by Type
11.3 Asia Pacific Vaccine Adjuvants Market Forecast by Route of Administration
11.4 Asia Pacific Vaccine Adjuvants Market Forecast by Disease Type
11.5 Asia Pacific Vaccine Adjuvants Market Forecast by End-User
11.6 Japan Vaccine Adjuvants Market Forecast, 2021-2031
11.6.1 Introduction
11.6.2 Vaccine Gap to Offer Immense Growth Opportunities
11.6.3 Recovery Scenarios (V, U, W, L): Japan Vaccine Adjuvants Market Forecast, 2021-2031
11.7 China Vaccine Adjuvants Market Forecast, 2021-2031
11.7.1 China is the Largest Market in Asia Pacific Vaccine Adjuvants Market
11.7.2 Growing Population to Fuel Chinese Vaccine Adjuvants Market Growth
11.7.3 Recovery Scenarios (V, U, W, L): China Vaccine Adjuvants Market Forecast, 2021-2031
11.8 India Vaccine Adjuvants Market Forecast, 2021-2031
11.8.1 Indian Vaccine Adjuvants Market to Witness the Highest Growth Rate from 2021 to 2031
11.8.2 Recovery Scenarios (V, U, W, L): India Vaccine Adjuvants Market Forecast, 2021-2031
11.9 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031
11.9.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031
12 Latin America Vaccine Adjuvants Market, 2021-2031
12.1 Latin America Vaccine Adjuvants Market by Country Forecast 2021-2031
12.2 Latin America Vaccine Adjuvants Market Forecast by Type
12.3 Latin America Vaccine Adjuvants Market Forecast by Route of Administration
12.4 Latin America Vaccine Adjuvants Market Forecast by Disease Type
12.5 Latin America Vaccine Adjuvants Market Forecast by End-User
12.6 Brazil Vaccine Adjuvants Market Forecast, 2021-2031
12.6.1 Brazil Currently Dominates the Latin American Vaccine Adjuvants Market
12.6.2 Recovery Scenarios (V, U, W, L): Brazil Vaccine Adjuvants Market Forecast, 2021-2031
12.7 Mexico Vaccine Adjuvants Market Forecast, 2021-2031
12.7.1 Recovery Scenarios (V, U, W, L): Mexico Vaccine Adjuvants Market Forecast, 2021-2031
12.8 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031
12.8.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031
13 Middle East and Africa Vaccine Adjuvants Market, 2021-2031
13.1 Middle East and Africa Vaccine Adjuvants Market by Country Forecast 2021-2031
13.2 Middle East and Africa Vaccine Adjuvants Market Forecast by Type
13.3 Middle East and Africa Vaccine Adjuvants Market Forecast by Route of Administration
13.4 Middle East and Africa Vaccine Adjuvants Market Forecast by Disease Type
13.5 Middle East and Africa Vaccine Adjuvants Market Forecast by End-User
13.6 GCC Vaccine Adjuvants Market Forecast, 2021-2031
13.6.1 Recovery Scenarios (V, U, W, L): GCC Vaccine Adjuvants Market Forecast, 2021-2031
13.7 South Africa Vaccine Adjuvants Market Forecast, 2021-2031
13.7.1 Recovery Scenarios (V, U, W, L): South Africa Vaccine Adjuvants Market Forecast, 2021-2031
13.8 Rest of Middle East and Africa Vaccine Adjuvants Market Forecast, 2021-2031
13.8.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Vaccine Adjuvants Market Forecast, 2021-2031
14 Company Profiles
14.1 GSK
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2015-2019
14.1.3.2 EBIDTA, 2015-2019
14.1.3.3 Gross Profit, 2015-2019
14.1.4 Product Benchmarking
14.1.5 Recent Developments, 2020
14.2 CSL
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2015-2019
14.2.4 Product Benchmarking
14.2.5 Recent Developments, 2020
14.3 Agenus
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2015-2019
14.3.3.2 EBIDTA, 2015-2019
14.3.3.3 Gross Profit, 2015-2019
14.3.4 Product Benchmarking
14.3.5 Recent Developments, 2020
14.4 Adjuvance
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Recent Developments, 2020
14.5 Novavax
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2015-2019
14.5.3.2 EBIDTA, 2015-2019
14.5.3.3 Gross Profit, 2015-2019
14.5.4 Product Benchmarking
14.5.5 Recent Developments, 2020
14.6 SPI Pharma
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Product Benchmarking
14.7 Invivogen
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Product Benchmarking
14.8 Avanti Polar Lipids
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Recent Developments, 2020
14.9 Brenntag AG (Croda)
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2015-2019
14.9.3.2 EBIDTA, 2015-2019
14.9.3.3 Gross Profit, 2015-2019
14.9.4 Product Benchmarking
14.10 Seppic (A Subsidiary of Air Liquide Group)
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Recent Developments, 2020
14.11 MVP Laboratories, Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.12 OZ Biosciences
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 Dynavax
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2015-2019
14.13.3.2 EBIDTA, 2015-2019
14.13.4 Product Benchmarking
14.13.5 Recent Developments, 2020
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations
List of Tables
Table 1 Global Vaccine Adjuvants Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Vaccine Adjuvants Market for Pathogen Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 4 Global Vaccine Adjuvants Market for Pathogen Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Vaccine Adjuvants Market for Pathogen Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Vaccine Adjuvants Market for Pathogen Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Vaccine Adjuvants Market for Pathogen Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 9 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Vaccine Adjuvants Market for Particulate Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 14 Global Vaccine Adjuvants Market for Particulate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Vaccine Adjuvants Market for Particulate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Vaccine Adjuvants Market for Particulate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Vaccine Adjuvants Market for Particulate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Vaccine Adjuvants Market for Combination Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 19 Global Vaccine Adjuvants Market for Combination Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 20 Global Vaccine Adjuvants Market for Combination Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 21 Global Vaccine Adjuvants Market for Combination Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 22 Global Vaccine Adjuvants Market for Combination Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 23 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 24 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Global Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 29 Global Vaccine Adjuvants Market for Intramuscular Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 30 Global Vaccine Adjuvants Market for Intramuscular Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Vaccine Adjuvants Market for Intramuscular Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Vaccine Adjuvants Market for Intramuscular Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Vaccine Adjuvants Market for Intramuscular Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global Vaccine Adjuvants Market for Subcutaneous Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 35 Global Vaccine Adjuvants Market for Subcutaneous Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Global Vaccine Adjuvants Market for Subcutaneous Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Global Vaccine Adjuvants Market for Subcutaneous Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Global Vaccine Adjuvants Market for Subcutaneous Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Global Vaccine Adjuvants Market for Intradermal Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Global Vaccine Adjuvants Market for Intradermal Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global Vaccine Adjuvants Market for Intradermal Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global Vaccine Adjuvants Market for Intradermal Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global Vaccine Adjuvants Market for Intradermal Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global Vaccine Adjuvants Market for Infectious Diseases Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 51 Global Vaccine Adjuvants Market for Infectious Diseases Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Vaccine Adjuvants Market for Infectious Diseases Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Vaccine Adjuvants Market for Infectious Diseases Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Vaccine Adjuvants Market for Infectious Diseases Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Vaccine Adjuvants Market for Cancer Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 56 Global Vaccine Adjuvants Market for Cancer Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Vaccine Adjuvants Market for Cancer Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Vaccine Adjuvants Market for Cancer Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Vaccine Adjuvants Market for Cancer Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 60 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 61 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 66 Global Vaccine Adjuvants Market for Pediatric Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 67 Global Vaccine Adjuvants Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 68 Global Vaccine Adjuvants Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 69 Global Vaccine Adjuvants Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 70 Global Vaccine Adjuvants Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 71 Global Vaccine Adjuvants Market for Adults Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 72 Global Vaccine Adjuvants Market for Adults Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 73 Global Vaccine Adjuvants Market for Adults Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 74 Global Vaccine Adjuvants Market for Adults Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 75 Global Vaccine Adjuvants Market for Adults Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 76 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 77 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 Global Vaccine Adjuvants Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 Global Vaccine Adjuvants Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 82 Global Vaccine Adjuvants Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Global Vaccine Adjuvants Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 Global Vaccine Adjuvants Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 Global Vaccine Adjuvants Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 North America Vaccine Adjuvants Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 87 North America Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 88 North America Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 89 North America Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 90 North America Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 91 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 92 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 97 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Vaccine Adjuvants Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 102 Europe Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 103 Europe Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 104 Europe Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 105 Europe Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 106 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 107 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 108 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 109 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 110 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 111 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 112 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 113 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 114 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 115 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 116 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 117 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 118 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 119 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 120 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 121 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 122 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 123 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 124 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 125 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 126 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 127 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 128 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 129 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 130 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 131 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 132 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 133 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 134 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 135 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 136 Asia Pacific Vaccine Adjuvants Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 137 Asia Pacific Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 138 Asia Pacific Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 139 Asia Pacific Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 140 Asia Pacific Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 141 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 142 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 143 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 144 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 145 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 146 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 147 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 148 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 149 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 150 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 151 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 152 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 153 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 154 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 155 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 156 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 157 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 Latin America Vaccine Adjuvants Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 162 Latin America Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 163 Latin America Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 164 Latin America Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 165 Latin America Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 166 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 167 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 172 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 177 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 178 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 179 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 180 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 181 Middle East and Africa Vaccine Adjuvants Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 182 Middle East and Africa Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Middle East and Africa Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 184 Middle East and Africa Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 185 Middle East and Africa Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 186 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 187 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 188 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 189 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 190 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 191 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 192 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 193 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 194 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 195 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 196 Rest of MEA Vaccine Adjuvants Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 197 Rest of MEA Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 198 Rest of MEA Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 199 Rest of MEA Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 200 Rest of MEA Vaccine Adjuvants Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 201 GSK: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 202 GSK: Product Portfolio
Table 203 GSK: Recent Developments, 2020
Table 204 CSL: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 205 CSL: Product Portfolio
Table 206 CSL: Recent Developments, 2020
Table 207 Agenus: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 208 Agenus: Product Portfolio
Table 209 Agenus: Recent Developments, 2020
Table 210 Adjuvance: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 211 Adjuvance: Product Portfolio
Table 212 Adjuvance: Recent Developments, 2020
Table 213 Novavax: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 214 Novavax: Product Portfolio
Table 215 Novavax: Recent Developments, 2020
Table 216 SPI Pharma: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 217 SPI Pharma: Product Portfolio
Table 218 Invivogen: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 219 Invivogen: Product Portfolio
Table 220 Avanti Polar Lipids: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 221 Avanti Polar Lipids: Product Portfolio
Table 222 Avanti Polar Lipids: Recent Developments, 2020
Table 223 Brenntag AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 224 Brenntag AG: Product Portfolio
Table 225 Seppic (A Subsidiary of Air Liquide Group): Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 226 Seppic (A Subsidiary of Air Liquide Group): Product Portfolio
Table 227 Seppic (A Subsidiary of Air Liquide Group): Recent Developments, 2020
Table 228 MVP Laboratories, Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 229 MVP Laboratories, Inc.: Product Portfolio
Table 230 OZ Biosciences: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 231 OZ Biosciences: Product Portfolio
Table 232 Dynavax: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 233 Dynavax: Product Portfolio
Table 234 Dynavax: Recent Developments, 2020
List of Figures
Figure 1 Global Vaccine Adjuvants Market: Market Dynamics
Figure 2 Global Vaccine Adjuvants Market: SWOT Analysis
Figure 3 PEST Analysis
Figure 4 Global Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ million, AGR %)
Figure 5 Global Vaccine Adjuvants Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 6 Global Vaccine Adjuvants Market for Pathogen Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 7 Global Vaccine Adjuvants Market for Pathogen Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 8 Global Vaccine Adjuvants Market for Pathogen Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 9 Global Vaccine Adjuvants Market for Pathogen Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 10 Global Vaccine Adjuvants Market for Pathogen Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 11 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 12 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 13 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 14 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 15 Global Vaccine Adjuvants Market for Adjuvant Emulsion Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 16 Global Vaccine Adjuvants Market for Particulate Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 17 Global Vaccine Adjuvants Market for Particulate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 18 Global Vaccine Adjuvants Market for Particulate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 19 Global Vaccine Adjuvants Market for Particulate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 20 Global Vaccine Adjuvants Market for Particulate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 21 Global Vaccine Adjuvants Market for Combination Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 22 Global Vaccine Adjuvants Market for Combination Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 23 Global Vaccine Adjuvants Market for Combination Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 24 Global Vaccine Adjuvants Market for Combination Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 25 Global Vaccine Adjuvants Market for Combination Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 26 Global Vaccine Adjuvants Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 27 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 28 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 29 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 30 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 31 Global Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ million, AGR %)
Figure 32 Global Vaccine Adjuvants Market Share Forecast by Type, 2021, 2026, 2031 (%)
Figure 33 Global Vaccine Adjuvants Market for Intramuscular Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 34 Global Vaccine Adjuvants Market for Intramuscular Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 35 Global Vaccine Adjuvants Market for Intramuscular Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 36 Global Vaccine Adjuvants Market for Intramuscular Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 37 Global Vaccine Adjuvants Market for Intramuscular Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 38 Global Vaccine Adjuvants Market for Subcutaneous Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 39 Global Vaccine Adjuvants Market for Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 40 Global Vaccine Adjuvants Market for Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 41 Global Vaccine Adjuvants Market for Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 42 Global Vaccine Adjuvants Market for Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 43 Global Vaccine Adjuvants Market for Intradermal Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 44 Global Vaccine Adjuvants Market for Intradermal Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 45 Global Vaccine Adjuvants Market for Intradermal Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 46 Global Vaccine Adjuvants Market for Intradermal Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 47 Global Vaccine Adjuvants Market for Intradermal Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 48 Global Vaccine Adjuvants Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 49 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 50 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 51 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 52 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 53 Global Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ million, AGR %)
Figure 54 Global Vaccine Adjuvants Market Share Forecast by Disease Type, 2021, 2026, 2031 (%)
Figure 55 Global Vaccine Adjuvants Market for Infectious Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 56 Global Vaccine Adjuvants Market for Infectious Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 57 Global Vaccine Adjuvants Market for Infectious Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 58 Global Vaccine Adjuvants Market for Infectious Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 59 Global Vaccine Adjuvants Market for Infectious Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 60 Global Vaccine Adjuvants Market for Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 61 Global Vaccine Adjuvants Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 62 Global Vaccine Adjuvants Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 63 Global Vaccine Adjuvants Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 64 Global Vaccine Adjuvants Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 65 Global Vaccine Adjuvants Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 66 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 67 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 68 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 69 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 70 Global Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ million, AGR %)
Figure 71 Global Vaccine Adjuvants Market Share Forecast by End-User, 2021, 2026, 2031 (%)
Figure 72 Global Vaccine Adjuvants Market for Pediatric Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 73 Global Vaccine Adjuvants Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 74 Global Vaccine Adjuvants Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 75 Global Vaccine Adjuvants Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 76 Global Vaccine Adjuvants Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 77 Global Vaccine Adjuvants Market for Adults Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 78 Global Vaccine Adjuvants Market for Adults Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 79 Global Vaccine Adjuvants Market for Adults Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 80 Global Vaccine Adjuvants Market for Adults Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 81 Global Vaccine Adjuvants Market for Adults Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 82 Global Vaccine Adjuvants Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 83 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 84 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 85 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 86 Global Vaccine Adjuvants Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 87 Global Vaccine Adjuvants Market Forecast by Region 2021-2031 (US$ million)
Figure 88 Global Vaccine Adjuvants Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 89 Global Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 90 Global Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 91 Global Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 92 Global Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 93 North America Vaccine Adjuvants Market Forecast by Country 2021-2031 (US$ million)
Figure 94 North America Vaccine Adjuvants Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 95 North America Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 96 North America Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 97 North America Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 98 North America Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 99 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 100 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 101 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 102 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 103 U.S. Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 104 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 105 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 106 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 107 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 108 Canada Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 109 Europe Vaccine Adjuvants Market Forecast by Country 2021-2031 (US$ million)
Figure 110 Europe Vaccine Adjuvants Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 111 Europe Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 112 Europe Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 113 Europe Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 114 Europe Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 115 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 116 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 117 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 118 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 119 Germany Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 120 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 121 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 122 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 123 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 124 UK Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 125 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 126 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 127 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 128 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 129 France Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 130 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 131 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 132 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 133 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 134 Italy Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 135 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 136 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 137 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 138 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 139 Spain Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 140 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 141 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 142 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 143 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 144 Rest of Europe Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 145 Asia Pacific Vaccine Adjuvants Market Forecast by Country 2021-2031 (US$ million)
Figure 146 Asia Pacific Vaccine Adjuvants Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 147 Asia Pacific Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 148 Asia Pacific Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 149 Asia Pacific Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 150 Asia Pacific Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 151 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 152 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 153 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 154 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 155 Japan Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 156 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 157 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 158 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 159 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 160 China Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 161 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 162 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 163 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 164 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 165 India Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 166 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 167 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 168 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 169 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 170 Rest of Asia Pacific Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 171 Latin America Vaccine Adjuvants Market Forecast by Country 2021-2031 (US$ million)
Figure 172 Latin America Vaccine Adjuvants Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 173 Latin America Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 174 Latin America Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 175 Latin America Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 176 Latin America Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 177 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 178 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 179 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 180 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 181 Brazil Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 182 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 183 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 184 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 185 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 186 Mexico Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 187 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 188 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 189 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 190 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 191 Rest of Latin America Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 192 Middle East and Africa Vaccine Adjuvants Market Forecast by Country 2021-2031 (US$ million)
Figure 193 Middle East and Africa Vaccine Adjuvants Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 194 Middle East and Africa Vaccine Adjuvants Market Forecast by Type, 2021-2031 (US$ million, AGR%)
Figure 195 Middle East and Africa Vaccine Adjuvants Market Forecast by Route of Administration, 2021-2031 (US$ million, AGR%)
Figure 196 Middle East and Africa Vaccine Adjuvants Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
Figure 197 Middle East and Africa Vaccine Adjuvants Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
Figure 198 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 199 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 200 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 201 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 202 GCC Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 203 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 204 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 205 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 206 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 207 South Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 208 Rest of Middle East and Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 209 Rest of Middle East and Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 210 Rest of Middle East and Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 211 Rest of Middle East and Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 212 Rest of Middle East and Africa Vaccine Adjuvants Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 213 GSK: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 214 GSK: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 215 GSK: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 216 CSL: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 217 Agenus: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 218 Agenus: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 219 Agenus: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 220 Novavax: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 221 Novavax: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 222 Novavax: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 223 Brenntag AG: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 224 Brenntag AG: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 225 Brenntag AG: Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 226 Dynavax: Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 227 Dynavax: EBIDTA, 2015-2019 (US$ Mn, AGR%)
Companies Profiled in the Report
Adjuvance
Agenus
Avanti Polar Lipids
Croda
CSL
Dynavax
GSK
Invivogen
MVP Laboratories
Novavax
OZ Biosciences
Seppic
SPI Pharma
List of Other Companies
Adimmune
Arabio
AstraZeneca
Bavarian Nordic
Beijing Institute of Biological Products Co., Ltd. (CNBG Subsidiary)
Bharat Biotech International Limited
Biken Co. Ltd.
Bilthoven Biologicals
Biological E. Limited
Biosonda USA
BIRMEX
Convac
Daiichi Sankyo
EuBiologics Co., Ltd.
GlaxoSmithKline Biologicals SA
Haffkine Bio Pharmaceutical Corporation Ltd
HLL Biotech Limited
IL-YANG PHARMACEUTICAL CO., LTD.
Incepta vaccine
Indian Immunologicals Ltd
Intervax
Janssen Vaccines Corp.
KM Biologics Co. Ltd.
MassBiologics
Microgen
Panacea Biotec Ltd.
PaxVax
Petrovax
POLYVAC
Rongan Biological
Royal (Wuxi) Bio-Pharmaceutical
Seqirus Limited
Serum Institute of India Pvt. Ltd.
Shanghai Fosun
Shanghai Institute of Biological Products Co.,Ltd (CNBG Subsidiary)
Shichuan Yuanda
SK Bioscience Co., Ltd.
VABIOTECH
Valneva
List of Organizations
Centers for Disease Control and Protection (CDC)
Centre for Biologics Evaluation and Research (CBER)
Developing Countries Vaccine Manufacturers Network (DCVMN)
European Medicines Agency (EMA)
Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Food and Drug Administration (FDA)
Global Alliance for Vaccines
Global Alliance for Vaccines and Immunization (GAVI)
International Financing Facility for Immunisation
National Health Service (NHS)
Pan American Health Organization (PAHO)
The Butantan Institute
The Indian Department of Biotech
The Ministry of Health, Labour and Welfare and the Health Service Bureau
UNICEF
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
